Abstract:Objective: To explore the role of single-nucleotide polymorphisms (SNPs) in hsa-miR-9 in non-small cell lung cancer (NSCLC). Methods: Log-rank and Cox regression analyses were conducted to assess the association of four functional SNPs of miR-9 with overall survival (OS) of Chinese patients with NSCLC. A reporter luciferase assay was performed to examine the relationship between the SNPs and transcriptional activity of miR-9. The expression of miR-9 in cells was detected by quantitative real-time PCR assay. Xenograft model was established in nude mice, which were treated with Lv-MiR-9-mimics or Lv-miR-9-inhibitor. A long noncoding RNA (lncRNA)-miR-9-messenger RNA (mRNA) competing endogenous RNA (ceRNA) network was established based on bioinformatics analyses. Results: We found that rs1501672 was associated with the prognosis of 1001 Chinese NSCLC patients (A>G, additive model: adjusted hazard ratio = 0.89, 95% confidence interval = 0.79-1.00, p = 0.056). Luciferase reporter assay showed higher luciferase activity with wild A allele than that with mutant G allele in 293T, SPC-A1, and A549 cell lines. The miR-9 level was significantly higher in lung cancer cells than normal lung cells. miR-9 was also over expressed in lung cancer tissue according to The Cancer Genome Atlas and gene expression omnibus databases. Xenograft models based on H1299 cells showed that lv-miR-9-inhibitor significantly decreased tumor growth compared with the lv-miR-9-NC group (p<0.001). Bioinformatics analysis showed that one target gene leukemia inhibitory factor receptor and two lncRNAs (KIAA0087 and GVINP1) were associated with OS of NSCLC patients. Conclusion: The rs1501672 of miR-9 was associated with the prognosis of NSCLC patients in the Chinese population. The lncRNA-miR-9-mRNA ceRNA network revealed potential molecular biological regulation pathways and prognostic biomarkers for NSCLC.

A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer

An Mir-502-Binding Site Single-Nucleotide Polymorphism In The 3 '-Untranslated Region Of The Set8 Gene Is Associated With Early Age Of Breast Cancer Onset

A functional single nucleotide polymorphism of SET8 is prognostic for breast cancer.

Genetic Variation in a Microrna-502 Minding Site in SET8 Gene Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population.

MiR-502/SET8 regulatory circuit in pathobiology of breast cancer.

MiR-502/SET8 Regulatory Circuit in Pathobiology of Breast Cancer

A Genetic Polymorphism In Pre-Mir-27a Confers Clinical Outcome Of Non-Small Cell Lung Cancer In A Chinese Population

Analysis of Genetic Variants and the Cerna Network of Mir-9 in Non-Small Cell Lung Cancer

Abstract A3: MicroRNA-related Polymorphisms Are Associated with Clinical Outcomes in Early Stage Non-Small Cell Lung Cancer Patients

MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer

Genetic Polymorphism of SLC31A1 is Associated with Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small-cell Lung Cancer Patients Through Modulating Microrna-Mediated Regulation.

Polymorphisms Of Microrna Sequences Or Binding Sites And Lung Cancer: A Meta-Analysis And Systematic Review

A Regulatory Circuitry Comprising TP53, Mir-29 Family, and SETDB1 in Non-Small Cell Lung Cancer.

The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility

Variations Within 3′-UTR of MDM4 Gene Contribute to Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Following Platinum-Based Chemotherapy

The Screening of the Functional Microrna Binding Site SNPs in Sporadic Colorectal Cancer Genes.

Sequence Variation in Mature MicroRNA-499 Confers Unfavorable Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy.

Genetic Polymorphisms in the Precursor MicroRNA Flanking Region and Non-Small Cell Lung Cancer Survival.

MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals.

Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.

Identification of a Functional Polymorphism Affecting Microrna Binding in the Susceptibility Locus 1q25.3 for Colorectal Cancer